ATX — Amplia Therapeutics Balance Sheet
0.000.00%
- AU$17.46m
- AU$12.95m
- AU$4.44m
Annual balance sheet for Amplia Therapeutics, fiscal year end - March 31st, AUD millions except per share, conversion factor applied.
2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Equivalents | |||||
Cash and Short Term Investments | 1.11 | 1.85 | 14.6 | 9.26 | 3.39 |
Net Total Receivables | 0.034 | 1 | 1.84 | 1.15 | 3.18 |
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 1.18 | 2.94 | 16.5 | 10.5 | 6.75 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 0.001 | 0.005 | 0.013 | 0.185 | 0.101 |
Net Intangible Assets | |||||
Other Long Term Assets | |||||
Total Assets | 9.12 | 10.9 | 24.5 | 18.7 | 14.8 |
Payable / Accrued | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 0.511 | 0.539 | 0.53 | 2.75 | 3.4 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Total Other Liabilities | |||||
Total Liabilities | 0.511 | 0.539 | 2.64 | 2.85 | 3.43 |
Common Stock | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | 8.61 | 10.3 | 21.8 | 15.8 | 11.4 |
Total Liabilities & Shareholders' Equity | 9.12 | 10.9 | 24.5 | 18.7 | 14.8 |
Total Common Shares Outstanding |